Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 26;6(1):6092.
doi: 10.4081/xeno.2016.6092. eCollection 2016 Jun 10.

Ameliorative Effect of Gallic Acid on Methotrexate-Induced Hepatotoxicity and Nephrotoxicity in Rat

Affiliations

Ameliorative Effect of Gallic Acid on Methotrexate-Induced Hepatotoxicity and Nephrotoxicity in Rat

Ebenezer Tunde Olayinka et al. J Xenobiot. .

Abstract

We investigated the protective effect of gallic acid (GA) against methotrexate (MTX)-induced hepatotoxicity and nephrotoxicity. Male Wistar rats were randomized into five groups (n = 6/group): I, control; II, MTX-treated for seven days; III, pre-treated with GA for seven days, followed by MTX for seven days; IV, co-treated with MTX and GA for seven days and V, GA for seven days. MTX caused a significant increase (P<0.05) in plasma biomarkers of nephrotoxicity (urea, creatinine) and hepatotoxicity (Bilirubin, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transferase) when compared with control. Furthermore, MTX caused a significant decrease in the activities of hepatic enzymic antioxidants (superoxide dismutase, catalase, glutathione S-transferase) and nonenzymic antioxidants (Vitamin C and glutathione), followed by a significant increase in hepatic malondialdehyde content. However, pre-treatment and co-treatment with gallic acid ameliorated the MTX-induced biochemical changes observed. Taken together, GA protected against MTX-induced hepatotoxicity and nephrotoxicity in rats, by reducing the impact of oxidative damage to tissues.

Keywords: Methotrexate; gallic acid; hepatotoxicity; nephrotoxicity; rat.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Chemical structure of methotrexate (A) and gallic acid (B).
Figure 2.
Figure 2.
Ameliorative effect of gallic acid pre-treatment and co-treatment on methotrexate-induced reduction in hepatic glutathione S-transferase (GST) activity in rats. Data are expressed as mean ± S.D for six rats in each group. *Significantly different from the control (P<0.05); asignificantly different from the methotrexate group (P<0.05).
Figure 3.
Figure 3.
Ameliorative effect of gallic acid pre-treatment and co-treatment on methotrexate-induced reduction in hepatic vitamin C level in rats. Data are expressed as mean ± S.D for six rats in each group. *Significantly different from the control (P<0.05); asignificantly different from the methotrexate group (P<0.05).
Figure 4.
Figure 4.
Ameliorative effect of gallic acid pre-treatment and co-treatment on methotrexate-induced reduction in hepatic glutathione (GSH) level in rats. Data are expressed as mean ± S.D for six rats in each group. *Significantly different from the control (P<0.05); asignificantly different from the methotrexate group (P<0.05).
Figure 5.
Figure 5.
Ameliorative effect of gallic acid pre-treatment and co-treatment on methotrexate-induced increase in hepatic level of lipid peroxidation (MDA) in rats. Data are expressed as mean ± S.D for six rats in each group. *Significantly different from the control (P<0.05); asignificantly different from the methotrexate group (P<0.05).

References

    1. Sirotnak FM, Donsbach RC. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells. Cancer Res 1974;34:332-40. - PubMed
    1. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405-10. - PubMed
    1. Phillips DC, Woollard KJ, Griffiths HR. The anti-infammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol 2003;138:501-11. - PMC - PubMed
    1. Galivan J, Nimec Z, Balinska M. Regulation of methotrexate polyglutamate accumulation in vitro: effects of cellular folate content. Biochem Pharmacol 1983; 32:3344-7. - PubMed
    1. Koizumi S. Imparment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines. Jpn J Cancer Res 1988;79:1230-7. - PMC - PubMed

LinkOut - more resources